🐋 LEU ≈$1.1M Deep-OTM $200 Call Bought — A Bullish Bet on America's Only Uranium Enricher Into August

📅 June 30, 2026 | 🔥 Unusual Options Activity Detected

✅ Updated 2026-07-01: next-day OPRA OI confirms the OPEN (see RESOLVED box).

---

🎯 The Quick Take

Someone just paid ≈$1.1M in real cash, at the ask, for 1,000 contracts of the LEU Aug-21-2026 $200 call — a deep out-of-the-money strike sitting ≈23% above the stock's current price of ≈$162. This is a tape-confirmed bullish bet on Centrus Energy, the only U.S.-owned uranium enricher and the linchpin of America's nuclear-fuel independence push. With Q2 earnings due ≈August 4 and a potentially transformative $900M DOE HALEU contract still to be formally signed, a real buyer stepped up to the offer on a beaten-down (−39% YTD) nuclear-fuel name and made a high-conviction, lottery-leaning wager that a big catalyst arrives before expiration.

---

📊 Company Overview

Centrus Energy Corp. (NYSE: LEU) is the only U.S.-owned, U.S.-technology uranium enrichment company operating in the country — a uniquely positioned, policy-driven name sitting at the intersection of nuclear-fuel security, advanced reactors, and the AI-data-center power boom:

• Market Cap: ≈$3.16 billion
• Industry: Energy — Nuclear Fuel / Uranium Enrichment
• Current Price: ≈$161 (June 30, 2026), down ≈39% YTD — sitting roughly 65% below its late-2025 peak of $464.25
• 52-Week Range: $144.65 – $464.25
• Primary Business: Two segments — Low-Enriched Uranium (LEU), selling separative work units (SWU) and uranium to nuclear utilities worldwide; and Technical Solutions, which runs the HALEU (High-Assay Low-Enriched Uranium) demonstration cascade at Piketon, Ohio — the only NRC-licensed, U.S.-technology HALEU enrichment facility in the nation
• The story in one sentence: Centrus is the structural winner of U.S. nuclear-fuel independence policy — it holds a $900M DOE HALEU task order, a $3.9B backlog to 2040, and a landmark HALEU supply agreement with Oklo for five SMR reactors — and it's down 39% YTD because the market is waiting for contingent catalysts to formally close

---

💰 The Option Flow Breakdown

📊 What Just Happened

At 10:32:37 ET on June 30, 2026, a trader paid up for a deep-OTM bullish call on LEU. The trade was a clean, single-leg, regular electronic execution — no block cross, no negotiated block, no spread. The fill came in at 83% across the bid-ask spread, meaning the buyer was essentially paying the ask to get done. That is a genuine BUY-side aggressor print: the buyer was not waiting for price to come to them.

The Trade (June 30, 2026):

⚡ Lit execution, paid up: This is a regular electronic trade — the buyer took the offer on the open market. Not a block cross, not a negotiated off-market print. The 83%-across-NBBO fill tells you there was urgency: the buyer consumed displayed size near the ask rather than working a limit order. This is as "real buy" as it gets on the tape.

---

✅ Open/Close Check — RESOLVED via Next-Day OPRA OI

✅ RESOLVED — OPEN CONFIRMED. The July 1 pre-market OPRA snapshot (reflecting June 30 EOD) is in, and it confirms this was a fresh opening long-call position.

Plain English: OI rose from 75 to 1,196 (+1,121), matching the 1,000-lot print — a fresh opening long-call (BTO). Bullish read confirmed.

---

🤓 What This Actually Means — Plain English

Let's decode this step by step:

What the buyer did: Paid $11.00 per contract × 1,000 contracts = ≈$1.1M out of pocket, near the ask, to open a new long call position on LEU with the August 21, 2026 expiration.

Why the $200 strike is such a stretch: LEU is trading at ≈$162. The $200 call is ≈23.5% out of the money — the stock needs to rally more than $38 from where it is today just for the option to have intrinsic value at expiration. The full breakeven is even higher: $200 + $11 = $211, requiring a ≈30% rally from the trade price. That's not a "I think LEU drifts a bit higher" bet. That is a bet on a major, catalyst-driven re-rating.

This is a convex, lottery-leaning position — and the buyer knows it. The most likely outcome is this expires worthless and the buyer loses $1.1M. They are paying for a ticket to an asymmetric payoff: if LEU reaches $220 by August 21, these calls are worth ≈$20 each — nearly doubling the investment. If LEU somehow reaches $240 (analyst consensus territory), the calls are worth ≈$40 — a 260% gain. The buyer is sizing the risk: ≈$1.1M is a defined, capped maximum loss in exchange for uncapped upside in a high-catalysts window.

The August 21 expiration is deliberate — it captures the two biggest near-term binary events:

1. Q2 2026 earnings on ≈August 4 — a potential swing catalyst landing roughly 17 days before expiration
2. The definitive DOE $900M HALEU task-order signing — still pending, expected any time in 2H 2026, and capable of re-rating the stock double-digits on announcement day

Why now? LEU is down ≈39% YTD and trades at roughly a third of its late-2025 high. Someone stepping up with ≈$1.1M at the offer — on a thin, volatile nuclear-fuel name with a massive catalyst pipeline — is expressing the view that the market has over-punished the stock and that a reversal is coming before mid-August.

In plain English: A believer in the US nuclear-fuel story is making a structured, limited-risk, convex wager that Centrus gets its catalyst before August 21. If the catalyst comes, the payoff is large. If it doesn't, $1.1M is the ticket price.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

Centrus Energy is one of the steepest decliners in the nuclear/uranium space YTD. The stock peaked near $464 in late 2025, entered 2026 already off its highs, then continued lower on a string of negative developments: a weak Q4 2025 print, a 63% YoY GAAP net-income decline in Q1 2026, and softening uranium spot prices. The stock sank another 13.5% in May 2026 alone. At ≈$162, LEU is near its 52-week low of $144.65.

Key chart observations:

• 📉 Sustained downtrend from $464 high — no signs yet of a trend reversal; buyers have not been able to hold any meaningful bounces
• 🛡️ $144–$150 zone = 52-week low cluster — this is the structural floor bulls must defend; a clean break below invites further selling with limited technical support beneath
• 📊 Consolidating in the $155–$175 range — the stock appears to be searching for a base, but the trend is unambiguously down-and-sideways until a hard catalyst breaks the pattern
• ⚡ Policy/headline driven — this is not a stock that moves on technical levels; a single DOE announcement or uranium price print can move LEU 15–20% in a session, making fundamental catalysts far more important than chart structure

Gamma-Based Support & Resistance Analysis

Current Price: ≈$162 | GEX Reference Price: $164.60

One important note upfront: LEU's gamma exposure is thin compared to large-cap names. This is a smaller-float, lower open-interest stock where the total gamma footprint across the chain is a fraction of what you'd see in, say, AMD or SPY. That has a meaningful implication: market-maker gamma hedging provides less price-dampening than on a mega-cap. LEU can move through these gamma levels quickly — especially on headline catalysts. So lean on the implied move analysis (next section) and the underlying fundamentals more than the gamma map for direction sizing.

With that said, here is what the current GEX data tells us:

🔵 Put Gamma / Support Zones (Blue Bars Below Price):

• $165 strike — the highest total gamma concentration closest to current spot (total GEX ≈0.132); put gamma dominates here (≈0.096 vs call gamma ≈0.036), which acts as a near-term gravity and support zone just above the current print
• $160 strike — secondary nearby support (total GEX ≈0.112); the stock has been oscillating around this level, and put gamma here provides a modest dealer-hedging floor
• $150 strike — the strongest put-gamma wall in the entire chain (total GEX ≈0.165); if LEU approaches $150, dealer put-hedging flows provide the deepest support; this is the level the bull case cannot afford to lose
• $145 strike — additional put gamma (total GEX ≈0.107); right at the 52-week low zone

🟠 Call Gamma / Resistance Zones (Orange Bars Above Price):

• $180 strike — first notable call gamma resistance above current price (total GEX ≈0.123, call GEX ≈0.053); a modest ceiling, but the stock would need a real catalyst to clear it cleanly
• $185 strike — secondary resistance (total GEX ≈0.106)
• $200 strike — the dominant call gamma level in the chain above spot (call GEX ≈0.117, net GEX +0.095 — the only clearly call-gamma-dominant level); this is where the option market has positioned the most call-side gamma concentration, and it is exactly the strike today's buyer targeted. In gamma terms, $200 is the ceiling; in option terms, it is where $1.1M was just committed

What this means: The $150 zone is the critical structural support — lose it and the technical picture deteriorates fast. The near-term pivot is the $160–$165 zone. For a bull move, the first real gamma ceiling is $180, then the $200 call wall — which, notably, is both the primary resistance in the gamma map AND the target of today's trade.

Net GEX bias: Negative (put gamma dominates net across most strikes) — overall gamma positioning skews toward downside hedging, consistent with the stock's beaten-down technical profile.

Implied Move Analysis

Options market pricing for LEU by key expirations (from ≈$164.47 reference price):

Key takeaways:

The options market is pricing LEU as a genuinely volatile, wide-ranging stock over the next several months — and that implied volatility structure is directly relevant to today's trade:

• The implied range for August 21 expiration is approximately $112 to $217 from the ≈$164 reference price (±≈32%)
• The LEU20260821C200 call strike of $200 sits inside that upper range — the options market itself is saying there is some probability LEU reaches $200 by August 21
• The breakeven of $211 (= $200 strike + $11 premium) is also inside the $217 upper bound — making this a trade where the vol surface says "this could work," not a trade completely outside what the market prices as possible
• The July OPEX range extends to $192.12 — meaning pre-earnings, the market is pricing about a ±17% move by mid-July alone. This is a volatile name

Translation for regular folks: The options market is saying LEU could plausibly trade anywhere from $112 to $217 by the time August 21 rolls around. The $200 call buyer is betting on the upper part of that range materializing — which is unlikely but not impossible. If LEU hits even $190 by earnings and runs on a strong print or DOE announcement, the $200 calls move from nearly worthless to suddenly worth watching.

---

🎪 Catalysts

🔥 Upcoming Catalysts (Events Into and Beyond the Aug 21 Expiration)

Q2 2026 Earnings — ≈August 4, 2026 (BEFORE EXPIRY — the big near-term binary)

LEU reports Q2 2026 results on approximately August 4, 2026 — roughly 17 days before the August 21 options expiration. This is the most immediately actionable catalyst in the thesis:

• Watch: Progress toward the full-year $450M–$500M revenue guide (raised after Q1); SWU pricing trend (Q1 saw pricing +52% YoY — can it hold?); Technical Solutions / HALEU contract revenue ramp; any update on the definitive $900M DOE agreement; ATM equity issuance to date (dilution gauge); updated backlog vs the $3.9B figure
• The GAAP vs adjusted split: Q1 2026 adjusted EPS surprised by ≈884% vs consensus estimates, but GAAP net income fell 63% YoY on higher advanced-technology and SG&A costs. The market punished the GAAP decline, not the adjusted beat. Q2 needs to show the GAAP picture improving — or it reinforces the downtrend

Note: Q2 2026 earnings (≈August 4) is a separate event from the August 21 expiration date. The expiry captures the full post-earnings reaction period.

Definitive DOE $900M HALEU Task-Order Agreement (2H 2026 — the biggest pending binary)

On January 5, 2026, DOE selected Centrus for a $900M task order to expand Piketon for commercial-scale HALEU production, with an additional option up to $170M for HALEU deliveries. But this selection is still subject to negotiation of a definitive contract — the formal signing has not occurred. When it does:

• ≈$900M of conditional federal funding converts to a firm government obligation
• It unlocks a cascade of customer financing, converting the $2.3B in conditional LEU customer commitments into firm contracts
• Combined with existing contract funding, it could lift total capacity toward ≈$2.8B
• First new commercial capacity at Piketon is targeted for 2029 — distinct from the 2026 signing

This signing could come any business day. The option buyer's August 21 window gives roughly 7 weeks of runway for this announcement. Whether or not it comes before expiry is the single most important unknown in this trade.

Oklo SMR HALEU Supply Agreement (June 2026 — recently signed, sets the template)

Centrus signed an agreement to supply domestic HALEU to power five Oklo Aurora reactors, with the companies also exploring a HALEU deconversion joint venture. This is the first concrete advanced-reactor off-take deal — and it is the template for the next wave of SMR/advanced-reactor developer agreements that would convert the $2.3B conditional pipeline to firm financing. Additional similar deals with other advanced-reactor developers are the next logical catalyst.

Russian-Import Waiver Wind-Down (structural — waivers terminate January 1, 2028)

Under the Prohibiting Russian Uranium Imports Act, waiver allotments step down through 2027 and all waivers terminate January 1, 2028 (the ban itself runs to 2040). Each annual tightening structurally disadvantages Russian enrichers and advantages domestic capacity like Centrus. This is not an August 2026 catalyst per se — it is the multi-year policy engine underwriting the entire bull case. Any acceleration of this timeline, new federal nuclear-fuel funding, or Tenex export-license friction would be an incremental tailwind.

Analyst Price Target Range (for context): Consensus sits at ≈$238–$265 average, with B. Riley at $295 (Buy) on the high end and UBS cutting to $170 and Citi to ≈$218–$225 more recently. The $200 call strike is below even the most cautious bullish analyst target — which puts it squarely within the range of what the sellside considers reasonable fair value on the stock.

📋 Recent Catalysts (Already Happened)

Q1 2026 Earnings — May 5, 2026 (mixed reception)

• Revenue $76.7M, +5% YoY; adjusted EPS $1.05–$1.19 (≈884% beat vs estimates)
• But GAAP net income fell 63% YoY on higher advanced-technology costs and SG&A; the market focused on the GAAP miss, not the adjusted beat
• Full-year revenue guidance raised to $450M–$500M; capital deployment $350M–$500M; $1.87B cash on hand

$560M Oak Ridge Centrifuge Manufacturing Investment (Q1/Q2 2026)

• Centrus launched a $560M investment at Oak Ridge, TN, adding 100+ jobs, with Fluor as EPC partner and Geiger Brothers as Piketon construction contractor — the physical buildout phase is underway

2026 Annual Meeting — June 18, 2026

• Shareholders approved director elections and governance items; no material surprises

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and the catalyst calendar through August 21:

📈 Bull Case (≈15% probability — requires a hard catalyst)

Target: $200–$217 by August 21, 2026

How we get there:

• Q2 earnings on ≈August 4 show improving GAAP trend, revenue tracking to $475M+ full-year, management signals the DOE definitive agreement is imminent
• The definitive $900M DOE HALEU task-order agreement is signed before or around the earnings call — the single biggest binary trigger
• Uranium spot recovers toward $94+ — directly re-rates LEU segment economics
• One or more additional advanced-reactor off-take deals announced (following the Oklo template)
• Stock recovers toward the sellside consensus average of ≈$238–$265
• At $200, the $200 call has intrinsic value; at $211+, it is profitable at expiry

LEU20260821C200 P&L in the bull case:

• Stock at $200 at Aug 21 expiry: intrinsic value ≈$0 — recover pennies above cost
• Stock at $211 at Aug 21 expiry: breakeven (call worth $11 = premium recouped)
• Stock at $220 at Aug 21 expiry: call worth ≈$20 — ≈80% gain on premium
• Stock at $240 at Aug 21 expiry: call worth ≈$40 — ≈260% gain on premium

Probability: ≈15% — requires alignment of multiple contingent catalysts in a ≈52-day window on a stock in a sustained downtrend. The upside is real but objectively unlikely without a hard news trigger.

🎯 Base Case (≈55% probability — chop and consolidate)

Target: $155–$185 by August 21, 2026

Most likely scenario:

• Q2 earnings are mixed — revenue in-line, adjusted EPS decent, GAAP numbers still pressured by advanced-technology buildout costs
• DOE definitive agreement remains "in active negotiation" — no signing announcement by August 21
• Uranium spot stays in the $82–$90 range — neither a recovery nor a decisive new leg down
• Stock oscillates between the $150 put-gamma wall and the $180 call-gamma ceiling
• The LEU20260821C200 call expires worthless — the buyer loses ≈$1.1M

Probability: ≈55% — this is the base path for a beaten-down, catalyst-dependent stock waiting on binary government and financing events.

📉 Bear Case (≈30% probability — downtrend resumes)

Target: $144–$155 by August 21, 2026

What could go wrong:

• Q2 GAAP earnings disappoint again — GAAP net income falls further; analysts cut estimates and the market re-tests the 52-week low
• DOE agreement delayed or leaked terms disappoint — removes the primary re-rating catalyst
• Uranium spot breaks below $82 — commodity sentiment deteriorates
• ATM equity issuance accelerates — dilution overhang grows tangible
• Analysts continue cutting targets (UBS, Citi, Roth have all reduced in recent months)
• Stock breaks below the $150 gamma support wall — next structural floor is $144–$145 (52-week low territory)
• LEU20260821C200 call expires completely worthless — buyer loses 100% of ≈$1.1M

Probability: ≈30% — the downtrend and fundamental headwinds are real. The stock is down 39% for identifiable reasons.

---

💡 Trading Ideas

🚀 YOLO Trader — Replicate the Whale (With Eyes Wide Open)

Play: Buy the LEU Aug 21, 2026 $200 calls — exactly what today's ≈$1.1M buyer did

The pitch: A real buyer paid the offer to position for a nuclear-fuel catalyst before August 21. If the DOE signs the $900M agreement or Q2 earnings trigger a re-rating, these calls go from $11 to $20–$40. The August 21 implied upper range (≈$217) puts the $211 breakeven inside what the vol surface prices as reachable.

The hard truth: This is a lottery ticket. The ≈23% OTM strike with ≈52 days to expiry has a rough probability of finishing in-the-money in the 15–20% range. The most likely outcome is 100% loss of premium. The DOE signing may not come before August 21 — government timelines slip. The stock is in a downtrend.

If you participate:

• Sizing discipline is everything. Risk no more than 0.5–1% of your total portfolio on a trade like this. The ≈$1.1M buyer has a much larger capital base where this is a small percentage bet — do not replicate the dollar amount, replicate the portfolio-percentage logic
• Set a mental exit: if the stock rallies toward $185–$190 pre-earnings and the calls double, consider taking some off the table rather than holding to expiry
• The Q2 earnings date (≈August 4) is your last major catalyst before expiry — plan your exit around that event, not on August 21

Max loss: 100% of premium paid | Risk level: EXTREME | Skill level: Advanced only

⚖️ Swing Trader — Defined-Risk Bull Spread

Play: A bull call spread — buy something closer to the money and sell the $200 strike to reduce cost

Example structure: Buy the Aug 21 $180 call + Sell the Aug 21 $200 call — a $20-wide bull call spread

Why this could work:

• The $180 call is much closer to the money (≈$12 OTM from ≈$162 spot) — higher probability of value at expiry
• Selling the $200 call collects premium at the gamma-wall level where today's trade was struck, directly offsetting part of your cost
• Defined risk: max loss = net debit paid for the spread, regardless of how far LEU falls
• Captures the full Q2 earnings (≈August 4) catalyst before the August 21 expiry

Illustrative economics (verify with live quotes):

• $180 call approximate cost: ≈$8–$12 based on current IV levels
• $200 call premium collected: ≈$7–$11 (today's print was $11)
• Net debit: potentially very low or near zero depending on exact pricing
• Max gain: $20 (spread width) minus net debit — if LEU is above $200 at expiry
• Breakeven: ≈$180 + net debit

Risk level: Moderate | Skill level: Intermediate

🛡️ Premium Collector — Sell Puts at Support, Collect Premium While Waiting

Play: Sell cash-secured puts at the $150 gamma support level — collect premium while expressing a "LEU doesn't break its 52-week low" thesis

Why this works:

• The $150 strike is the strongest put-gamma wall in the chain (total GEX ≈0.165) — dealer support intensifies near this level
• Selling the Aug 21 $150 put collects premium income while your effective entry on LEU stock (if assigned) is $150 — a level near the 52-week low
• If LEU stays above $150, you keep the premium and never take delivery
• This is a fundamentally different approach to the same bullish thesis: you're getting paid to commit to buying LEU at a price the market hasn't seen since its lows

The risk: If LEU breaks below $150 — which the bear case puts at 30% probability — you are assigned stock at $150 with a paper loss from there. Selling puts requires you to be truly willing to own LEU at the strike price.

Risk level: Moderate (with ability to take stock assignment) | Skill level: Intermediate

🌱 Entry-Level Investor — Understand Before You Trade

If you are new to options and finding this trade exciting, here is what you need to know:

The ≈$1.1M call trade is a high-risk speculation, not a signal to blindly follow. Options on beaten-down, policy-driven names like LEU are expensive, directional, and time-sensitive. The most likely outcome for today's $200 call is that it expires worthless.

Before you consider any options position on LEU:

• Understand the nuclear-fuel thesis — this company's future is tied to government contracts and commodity prices, both of which can reverse quickly
• If you believe in the long-term story, consider buying LEU stock outright at ≈$162 — 65% off its high — rather than speculative deep-OTM options with a 52-day clock
• If you are curious about options, start by paper-trading this setup (simulated, not real money) through the August 4 earnings date and observe what happens

Risk level: Learn first, trade second

---

⚠️ Risk Factors

Don't ignore these before making any decision:

• ⏰ Deep-OTM = high probability of total loss: A $200 call on a ≈$162 stock with ≈52 days to expiry has roughly a 15–20% probability of finishing in-the-money. The most probable outcome is that the entire ≈$1.1M premium expires worthless. This is not a hedge or a conservative play.

• 💸 Dilution overhang is structural: The $1B at-the-market equity program and $805M in convertible notes are significant per-share diluters. ATM issuance can act as a ceiling on sharp rallies — the company raises money into price strength.

• 🏛️ DOE agreement is NOT yet signed: The $900M HALEU task order is still "subject to negotiation of a definitive contract." Government contract negotiations routinely slip by months. If the signing does not happen before August 21, the option buyer's primary catalyst is missed.

• 📉 Down 39% YTD for real reasons: Q4 2025 earnings missed badly, GAAP net income fell 63% YoY in Q1 2026 on higher advanced-technology costs, and uranium spot is drifting near ≈$86/lb vs January's $94+. UBS, Citi, and Roth have all cut price targets in recent months. This is not random noise — the fundamental picture is mixed at best.

• ☢️ Policy reversal risk: LEU is a pure-play policy stock. Any softening of the Russian-import ban, unexpected waiver expansion, or shift in federal nuclear-fuel funding priorities directly undermines the core thesis. This is low probability but high impact.

• 🏗️ Execution risk on the $560M Oak Ridge buildout: First new commercial enrichment capacity is targeted for 2029 — years of capital spending before meaningful revenue contribution. The $2.3B in customer commitments is contingent on financing — not a financed, firm pipeline yet.

• 📊 Earnings quality concern: The 63% YoY GAAP net-income decline in Q1 is not a one-time item — it reflects higher advanced-technology costs that are structural to the buildout phase. If Q2 repeats this pattern, the stock has further to fall before finding its floor.

• ⚗️ Commodity exposure: Uranium/SWU spot prices directly affect LEU segment economics and investor sentiment. A further slide below $82/lb would be an incremental headwind on top of an already-challenged tape.

• 🎢 Thin float + high IV = gap risk in both directions: LEU can move 15–20% on a single policy headline. This cuts both ways: the bull case can materialize rapidly, but a negative DOE headline, earnings miss, or uranium-market leg down can gap the stock well below current support with limited warning.

---

🎯 The Bottom Line

Here's the deal: Someone paid ≈$1.1M in real cash, near the ask, for a deep-OTM call on America's only uranium enricher — a beaten-down, policy-sensitive stock sitting ≈65% below its late-2025 high. This is a tape-confirmed, genuine BUY-side print. Not a negotiated block, not a cross — a real buyer stepping up to the market offer.

What this trade is telling us:

• 🎯 A believer in the US nuclear-fuel thesis made a structured, capped-risk ($1.1M max loss) bet on a significant catalyst arriving before August 21
• 📅 The August 21 expiry is deliberate — it captures Q2 earnings (≈August 4) AND provides a 7-week window for the DOE definitive $900M agreement to print
• 🏛️ The $200 strike is not random — it sits at the primary call-gamma wall in the LEU chain, within the sellside's bull-case price-target range, and inside the options market's implied upper bound for August expiration
• 💡 The ≈$1.1M is small in absolute dollar terms for this type of institutional positioning — this is a high-conviction, percentage-allocation lottery bet, not an all-in trade

This is NOT a signal to blindly replicate. The most likely outcome is this expires worthless and the buyer loses $1.1M. What it tells you is that at least one market participant with real capital sees enough near-term upside potential to pay up for a deep-OTM structure into August.

If you own LEU stock:

• This call buyer is a fellow bull — they just expressed the same thesis in a different vehicle
• Watch ≈August 4 earnings for the near-term inflection; watch every morning for a DOE announcement (it can come any business day)
• The $150 gamma wall is your key downside reference — hold there and the technical floor is intact; break it and the next support is the 52-week low near $144

If you're watching from the sidelines:

• Post-Q2 earnings (≈August 5–7) will clarify whether the GAAP trend is improving
• The $155–$165 zone is a potential accumulation point for long-term investors who believe the nuclear-fuel-independence thesis — the stock is down 65% from its high on what may be temporary fundamental headwinds
• Do not replicate the $200 call directly unless you are fully prepared to lose 100% of the premium — that is the realistic base case

If you're bearish:

• The downtrend, analyst downgrades, and pending dilution are real and on your side
• The $150 gamma support and $144 52-week low are your trigger levels
• Be aware: a single DOE/policy headline can close a 15% short position in one session — manage your size accordingly

Mark your calendar — Key dates:

• 📅 ≈August 4, 2026 — Q2 2026 earnings report (confirm exact date at Investing.com and Zacks)
• 📅 Any business day, 2H 2026 — Definitive DOE $900M HALEU task-order signing (watch Centrus IR for the announcement)
• 📅 August 21, 2026 — The LEU20260821C200 call expires; ✅ next-day OPRA OI is now in and RESOLVED the open — OI rose 75 → 1,196 (Δ +1,121 ≈ the 1,000-lot print), confirming a fresh opening long call (BTO)
• 📅 January 1, 2028 — All Russian enriched-uranium import waivers terminate under the Prohibiting Russian Uranium Imports Act — the structural policy tailwind accelerates from here

Final verdict: Centrus Energy has one of the most binary, catalyst-dense profiles in the energy sector. The ≈$1.1M Aug 21 $200 call is a genuine, tape-confirmed bullish bet — paid the offer, opening position, nuclear-fuel conviction. For long-term investors, the nuclear-fuel-independence story (sole U.S. enricher, $3.9B backlog to 2040, $900M DOE task order, Oklo SMR deal, Russian-ban tailwind) remains compelling despite the YTD pain. But the near-term trade needs a catalyst — and that catalyst either comes before August 21 or it doesn't.

Patient bulls wait for the event. Impatient ones buy the $200 call and accept the odds.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial or investment advice. The deep-OTM LEU20260821C200 call analyzed here has a high probability of expiring worthless — anyone considering replicating this position should be fully prepared to lose their entire premium. Centrus Energy is a highly volatile, policy-sensitive, commodity-linked stock subject to binary events including government contract outcomes and uranium price moves; unusual options activity does not guarantee future performance. Always conduct independent research and consult a licensed financial advisor before making any trading decision.

---

About Centrus Energy: Centrus Energy Corp. is the only U.S.-owned, U.S.-technology uranium enrichment company, operating the nation's sole NRC-licensed HALEU enrichment cascade at Piketon, Ohio, and supplying enriched uranium and SWU to nuclear utilities worldwide. Market cap ≈$3.16 billion; sector: Energy — Nuclear Fuel / Uranium Enrichment.

---

Last updated: 2026-07-01 — open/close RESOLVED via next-day OPRA OI: OPEN confirmed (OI 75 → 1,196, Δ +1,121 ≈ size 1,000). Bullish long-call open holds.